Back to Results
First PageMeta Content
Drug discovery / Pharmaceutical industry / Clinical research / Lexicon Pharmaceuticals / TopoTarget / Pharmacology / Pharmaceutical sciences / Drug development


Corporate Introduction (NASDAQ: ENMD) January[removed]
Add to Reading List

Document Date: 2014-02-11 11:41:01

Open Document

File Size: 529,02 KB

Share Result on Facebook

Company

Corporate Introduction / /

Continent

North America / /

Country

China / United States / /

Event

FDA Phase / /

MedicalCondition

cancers / autoimmune disorders / call cancer / Cancer / multiple sclerosis / Refractory Hematological Malignancies / rheumatoid arthritis / negative breast cancer global trials Soft tissue sarcoma / Solid tumors / Autoimmune diseases / /

Person

Amit Oza / Daniela Matei / Wells Messersmith / Gini Fleming / Geoffrey Shapiro / Sherif Farag / Karen Yee / Ursula Matulonis / Aurora Kinases Angiogenic Kinases / Kian Behbakht / William Tew / /

Position

Private / /

Product

2ME-2 / ENMD-2076 / 2ME2 / CL-003 / /

SocialTag